H Bounameaux

Vorapaxar in Patients With Peripheral Artery Disease

Marc P. Bonaca, Benjamin M. Scirica, Mark A. Creager et al. · Circulation · 2013 · 296 citations · Full text

Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.

M Verstraete, H Bounameaux, F De Cock et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 155 citations

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.

D Collen, H Bounameaux, F De Cock et al. · Circulation · 1986 · 152 citations · Full text

Immunology, Acute Myocardial Infarction, Intravenous Infusion +17

Diagnosing pulmonary embolism: running after the decreasing prevalence of cases among suspected patients

Grégoire Le Gal, H Bounameaux · Journal of Thrombosis and Haemostasis · 2004 · 137 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +8

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Renée A. Douma, Minkang Tan, Roger E. G. Schutgens et al. · Haematologica · 2012 · 129 citations · Full text